Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 6 clinical trials
Smartphone Based aDOT Treatment With Fixed-Dose Elbasvir and Grazoprevir in PWIDs

People who Inject Drugs (PWIDs) constitute 60% of the approximately 5 million people in the United States infected with hepatitis C virus (HCV). Successful HCV treatment leading to sustained viral response (SVR) is associated with increased survival, but to date successful treatment of PWIDs has been limited. Treatment of PWIDs …

ribavirin
directly observed therapy
elbasvir
elbasvir/grazoprevir
substance use
  • 8 views
  • 08 Nov, 2020
  • 1 location
Grazoprevir/Elbasvir for Genotype 1b Chronic Hepatitis C After Liver or Kidney Transplantation

Grazoprevir/elbasvir combination therapy is highly effective in the treatment of genotype 1b chronic hepatitis C, and the drug-drug interaction with central immunosuppressant, such as tacrolimus

elbasvir
combination therapy
kidney transplant
grazoprevir
chronic hepatitis
  • 0 views
  • 15 Oct, 2020
  • 1 location
Impact of Hepatitis C Therapy and Bone Health

An evaluation of the impact of Elbasvir and Grazoprevir (EBR/GZR) HCV therapy on the heart risk and bone health of HCV mono-infected and HIV/HCV co-infected patients.

raltegravir
mono
elbasvir
emtricitabine
haart
  • 120 views
  • 08 Nov, 2020
  • 1 location
Transplanting Hepatitis C Kidneys Into Negative Kidney Recipients

This study is being conducted to determine safety and effectiveness of transplanting kidneys from Hepatitis C-positive donors into Hepatitis C-negative patients on the kidney transplant waitlist, who will then be treated with the appropriate direct-acting antiviral (DAA) after the single kidney transplantation.

dialysis
kidney transplant
  • 0 views
  • 24 Dec, 2020
  • 1 location
Transplanting Hepatitis C Lungs Into Negative Lung Recipients

This study is being conducted to determine safety and effectiveness of transplanting lungs from Hepatitis C-positive donors into Hepatitis C-negative patients on the lung transplant waitlist, who will then be treated with appropriate direct-acting antiviral (DAA) after transplantation.

lung transplant
  • 3 views
  • 09 Aug, 2020
  • 1 location
Hepatitis C (HCV) Cure and Kidney Health

The purpose of this study is to learn how 12 weeks of HCV treatment with elbasvir and grazoprevir (brand name Zepatier) impacts your kidney function.

elbasvir
elbasvir/grazoprevir
zepatier
HIV Infection
grazoprevir
  • 29 views
  • 08 Nov, 2020
  • 1 location